Literature DB >> 36085400

Inhibitors of soluble epoxide hydrolase on acute lung injury: a meta-analysis of preclinical studies.

Wei Tao1, Gang Xu1, Yi Luo1, Ping-Song Li2.   

Abstract

INTRODUCTION: This study investigated the effects of soluble epoxide hydrolase (sEH) inhibitors on acute lung injury (ALI) using the measure of meta-analysis.
METHODS: Relative publications were systematic reviewed and retrieved by searching electronic databases including the Cochrane Library, PubMed, China National Knowledge Infrastructure, Wanfang Data, and Google Scholar.
RESULTS: Seven animal studies were included in this meta-analysis. Our result showed that the lung injury scores (SMD = - 2.31, 95% CI - 3.50 to - 1.12) and lung wet to dry weight ratios (WMD-1.44, 95% CI - 1.69 to - 1.18) were reduced in sEH inhibitors-treated animals compared with control. The mortality was improved by sEH inhibitors at 48 h (RR = 0.62, 95% CI 0.42 to 0.92), 72 h, and 120 h, but not at 24 h (RR = 0.59, 95% CI 0.35 to 1.01) and 96 h, after induction of ALI model.
CONCLUSIONS: The sEH inhibitor is a potent candidate of pharmacological agents for ALI/acute respiratory distress syndrome, as its effects on improvement of lung injury and mortality in preclinical researches.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Acute lung injury; Inhibitors; Mortality; soluble epoxide hydrolase

Year:  2022        PMID: 36085400     DOI: 10.1007/s10787-022-01063-2

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   5.093


  24 in total

1.  Inhibition of soluble epoxide hydrolase attenuates hepatic fibrosis and endoplasmic reticulum stress induced by carbon tetrachloride in mice.

Authors:  Todd R Harris; Ahmed Bettaieb; Sean Kodani; Hua Dong; Richard Myers; Nipavan Chiamvimonvat; Fawaz G Haj; Bruce D Hammock
Journal:  Toxicol Appl Pharmacol       Date:  2015-03-28       Impact factor: 4.219

Review 2.  Modulation of mitochondrial dysfunction and endoplasmic reticulum stress are key mechanisms for the wide-ranging actions of epoxy fatty acids and soluble epoxide hydrolase inhibitors.

Authors:  Bora Inceoglu; Ahmed Bettaieb; Fawaz G Haj; Aldrin V Gomes; Bruce D Hammock
Journal:  Prostaglandins Other Lipid Mediat       Date:  2017-08-25       Impact factor: 3.072

3.  Suppression of chemotherapy-induced cytokine/lipid mediator surge and ovarian cancer by a dual COX-2/sEH inhibitor.

Authors:  Allison Gartung; Jun Yang; Vikas P Sukhatme; Diane R Bielenberg; Djanira Fernandes; Jaimie Chang; Birgitta A Schmidt; Sung Hee Hwang; David Zurakowski; Sui Huang; Mark W Kieran; Bruce D Hammock; Dipak Panigrahy
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-15       Impact factor: 11.205

Review 4.  Cyclooxygenase-2 Inhibitors as a Therapeutic Target in Inflammatory Diseases.

Authors:  Miguel D Ferrer; Carla Busquets-Cortés; Xavier Capó; Silvia Tejada; Josep A Tur; Antoni Pons; Antoni Sureda
Journal:  Curr Med Chem       Date:  2019       Impact factor: 4.530

Review 5.  Soluble epoxide hydrolase: gene structure, expression and deletion.

Authors:  Todd R Harris; Bruce D Hammock
Journal:  Gene       Date:  2013-05-20       Impact factor: 3.688

6.  Soluble epoxide hydrolase deficiency or inhibition attenuates diet-induced endoplasmic reticulum stress in liver and adipose tissue.

Authors:  Ahmed Bettaieb; Naoto Nagata; Daniel AbouBechara; Samah Chahed; Christophe Morisseau; Bruce D Hammock; Fawaz G Haj
Journal:  J Biol Chem       Date:  2013-04-10       Impact factor: 5.157

7.  sEH Inhibitor Tppu Ameliorates Cecal Ligation and Puncture-Induced Sepsis by Regulating Macrophage Functions.

Authors:  Zhihui Chen; Ying Tang; Jing Yu; Ruolan Dong; Yan Yang; Menglu Fu; Jinlan Luo; Shuiqing Hu; Dao Wen Wang; Ling Tu; Xizhen Xu
Journal:  Shock       Date:  2020-06       Impact factor: 3.533

8.  SYRCLE's risk of bias tool for animal studies.

Authors:  Carlijn R Hooijmans; Maroeska M Rovers; Rob B M de Vries; Marlies Leenaars; Merel Ritskes-Hoitinga; Miranda W Langendam
Journal:  BMC Med Res Methodol       Date:  2014-03-26       Impact factor: 4.615

9.  EETs reduces LPS-induced hyperpermeability by targeting GRP78 mediated Src activation and subsequent Rho/ROCK signaling pathway.

Authors:  Ruolan Dong; Danli Hu; Yan Yang; Zhihui Chen; Menglu Fu; Dao Wen Wang; Xizhen Xu; Ling Tu
Journal:  Oncotarget       Date:  2017-04-21

Review 10.  Advancing precision medicine for acute respiratory distress syndrome.

Authors:  Jeremy R Beitler; B Taylor Thompson; Rebecca M Baron; Julie A Bastarache; Loren C Denlinger; Laura Esserman; Michelle N Gong; Lisa M LaVange; Roger J Lewis; John C Marshall; Thomas R Martin; Daniel F McAuley; Nuala J Meyer; Marc Moss; Lora A Reineck; Eileen Rubin; Eric P Schmidt; Theodore J Standiford; Lorraine B Ware; Hector R Wong; Neil R Aggarwal; Carolyn S Calfee
Journal:  Lancet Respir Med       Date:  2021-07-23       Impact factor: 102.642

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.